Unlock this StockReport nowClick to Unlock

Bioventix Share Price

BVXP 3810p 0.0  0.0%
16/08/19 0.200k

Relative Strength (%)
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
Margin of Safety (beta)
Screens Passed 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 30th Jun 2013 2014 2015 2016 2017 2018 TTM 2019E 2020E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
Operating Margin %
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Last ex-div: 25th Oct, paid: 9th Nov more... Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p +20.7%

FINANCIAL BRIEF: For the six months ended 31 December 2018, Bioventix PLC revenues increased 2% to £4.4M. Net income decreased 3% to £2.7M. Revenues reflect Turnover increase of 24% to £4.4M. Net income was offset by Administrative Expenses increase of 7% to £656K (expense), R&D Expense - Tax Credit decrease of 56% to £8K (income), Interest Income - Non Bank decrease of 5% to £10K (income). Dividend per share increased from £0.25 to £0.30. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
Recent History
Latest interim period (ended 31st Dec '18) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
30th Jun 2019
30th Jun 2020

Price Target: 37.0
(-2.91% below Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
1 broker Broker Consensus Trend
Broker Recommendations for Bioventix
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
FinnCap Mark Brewer ,

Profile Summary

Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The Company specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing. The Company's non-vitamin D business consists of antibodies, NT proBNP (heart failure), testosterone, Free Triiodothyronine (FT3) (thyroid hormone), estradiol, and various drugs, such as tetrahydrocannabinol (THC)/cannabis, and progesterone. The Company offers products for indications, such as thyroid, fertility, oncology, cardiac, vitamin D, drug of abuse, infectious disease and miscellaneous. Its sheep hybridoma technology produces cell lines that secrete SMAs. The Company offers a panel of SMAs to 25-OH D and has various 25-OH D2 and 25-OH D3 specific antibodies. It sells its products through direct sales and through distributors.

Directors: P. Harrison (CEO) , Ian Nicholson (NEC) 54, Kim Tan (DRC) 55, T. Turner (DRC) , Nick McCooke (NED) ,

No. of Employees: 15 No. of Shareholders: n/a

Last Annual June 30th, 2018
Last Interim December 31st, 2018
Incorporated October 7, 2003
Public Since April 29, 2014
Shares in Issue 5,142,674
Free Float 4.31m (83.9%)
Sector Healthcare
Industry Biotechnology & Medical Research
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Eligible for an ISA? a SIPP?

BVXP Share Price Performance BVXP Share Price Quote
0.0  0.0%
Traded 2:06pm · Minimum 15 min delayed · NMS: 0.200k

Latest BVXP News Announcements (delayed)

Upcoming BVXP Events
Friday 6th December, 2019 (estimate)
Bioventix PLC Annual Shareholders Meeting

Recent ↓
Thursday 11th April, 2019
Dividend For BVXP.L
Thursday 28th March, 2019
Half Year 2019 Bioventix PLC Earnings Release
Friday 22nd March, 2019 (estimate)
Half Year 2019 Bioventix PLC Earnings Release
Thursday 6th December, 2018
Bioventix PLC Annual Shareholders Meeting
Thursday 25th October, 2018
Dividend For BVXP.L
Thursday 25th October, 2018
Dividend For BVXP.L
Monday 8th October, 2018
Full Year 2018 Bioventix PLC Earnings Release
Thursday 5th April, 2018
Dividend For BVXP.L
Friday 23rd March, 2018 (estimate)
Half Year 2018 Bioventix PLC Earnings Release
Thursday 14th December, 2017
Bioventix PLC Annual Shareholders Meeting
Thursday 26th October, 2017
Dividend For BVXP
Thursday 26th October, 2017
Dividend For BVXP
Monday 16th October, 2017
Full Year 2017 Bioventix PLC Earnings Release
Thursday 6th April, 2017
Dividend For BVXP.L
Friday 24th March, 2017
Half Year 2017 Bioventix PLC Earnings Release
Tuesday 6th December, 2016
Bioventix PLC Annual Shareholders Meeting
Thursday 27th October, 2016
Dividend For BVXP.L
Thursday 27th October, 2016
Dividend For BVXP.L
Monday 17th October, 2016
Full Year 2016 Bioventix PLC Earnings Release
Thursday 7th April, 2016
Dividend For BVXP.L

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2019.

Should you buy BVXP

Access BVXP Analytics Now!

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis